China faces a million deaths a year from antibiotic-resistant superbugs and a loss of $20 trillion by 2050, an economist and former top Goldman Sachs executive said Thursday. Beijing should "take ownership" of anti-microbial resistance (AMR) when it hosts the G20 summit next year, said Jim O'Neill, the leader of a British government-commissioned review on the subject. O'Neill, former chief economist at the US investment bank and chairman of Goldman Sachs Asset Management, said that the threat put "China's remarkable economic performance in the last decade and its enormous future potential" in jeopardy. The review, announced last year by British Prime Minister David Cameron, has found that by 2050, drug-resistant infections could cut global gross domestic product by 2.0 to 3.5 percent and kill 10 million people a year around the world.
via Health News Headlines - Yahoo News http://ift.tt/1yc9s29
No comments:
Post a Comment